Brion S. Maher

Brion S. Maher

Auto-generated profile, based on publicly available information

Brion S. Maher

Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
XMXiangrui Meng
Xiangrui Meng
GNGeorgina Navoly
Georgina Navoly
OGOlga Giannakopoulou
Olga Giannakopoulou
DLDaniel Levey
Daniel Levey
DKDora Koller
Dora Koller
BPBioBank Japan Project
BioBank Japan Project
Most genome-wide association studies (GWAS) of major depression (MD) have been conducted in samples of European ancestry. Here we report a multi-ancestry GWAS of MD, adding data from 21 cohorts with 88,316 MD cases and 902,757 controls to previously reported data. This analysis used a range of measures to define MD and included samples of African (36% of effective sample size), East Asian (26%) and South Asian (6%) ancestry and Hispanic/Latin American participants (32%). The multi-ancestry GWAS identified 53 significantly associated novel loci. For loci from GWAS in European ancestry samples, fewer than expected were transferable to other ancestry groups. Fine mapping benefited from additional sample diversity. A transcriptome-wide association study identified 205 significantly associated novel genes. These findings suggest that, for MD, increasing ancestral and global diversity in genetic studies may be particularly important to ensure discovery of core genes and inform about transferability of findings.

13 May 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NSNora I. Strom
Nora I. Strom
ZGZachary F. Gerring
Zachary F. Gerring
MGMarco Galimberti
Marco Galimberti
DYDongmei Yu
Dongmei Yu
MHMatthew W. Halvorsen
Matthew W. Halvorsen
CGChris German
Chris German
Obsessive–compulsive disorder (OCD) affects ~1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3 and CTNND1 and multiple genes in the major histocompatibility complex (MHC) region. We estimated that ~11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and the cortex, along with D1 and D2 type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa and Tourette syndrome and was negatively associated with inflammatory bowel diseases, educational attainment and body mass index.

28 September 2015 in Current Epidemiology Reports
Verified
Journal Article
Closed access
PDF file
BMBrion S. Maher
Brion S. Maher

23 October 2021 in medRxiv
Verified
Preprint
Open access
PDF file
NSNora I. Strom
Nora I. Strom
DYDongmei Yu
Dongmei Yu
ZGZachary F. Gerring
Zachary F. Gerring
MHMatthew W. Halvorsen
Matthew W. Halvorsen
AAAbdel Abdellaoui
Abdel Abdellaoui
MMManuel Mattheisen
Manuel Mattheisen
Obsessive-compulsive disorder (OCD) is a heritable disorder, but no definitive, replicated OCD susceptibility loci have yet been identified by any genome-wide association study (GWAS). Here, we report results from a GWAS in the largest OCD case-control sample (N = 14,140 OCD cases and N = 562,117 controls) to date. We explored the genetic architecture of OCD, including its genetic relationships to other psychiatric and non-psychiatric phenotypes. In the GWAS analysis, we identified one SNP associated with OCD at a genome-wide significant level. Subsequent gene-based analyses identified additional two genes as potentially implicated in OCD pathogenesis. All SNPs combined explained 16% of the heritability of OCD. We show sub-stantial positive genetic correlations between OCD and a range of psychiatric disorders, including anxiety disorders, anorexia nervosa, and major depression. We thus for the first time provide evidence of a genome-wide locus implicated in OCD and strengthen previous literature suggesting a polygenic nature of this disorder.

13 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
NSNora I. Strom
Nora I. Strom
ZGZachary F. Gerring
Zachary F. Gerring
MGMarco Galimberti
Marco Galimberti
DYDongmei Yu
Dongmei Yu
MHMatthew W. Halvorsen
Matthew W. Halvorsen
2I23Andme Inc.
23Andme Inc.
Obsessive-compulsive disorder (OCD) affects ∼1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3, CTNND1 and multiple genes in the MHC region. We estimated that ∼11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and cortex, along with D1- and D2-type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all of the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa, and Tourette syndrome, and was negatively associated with inflammatory bowel diseases, educational attainment, and body mass index.

17 March 2022 in Drug and Alcohol Dependence Reports
Verified
Journal Article
Open access
DSDavid W. Sosnowski
David W. Sosnowski
AJAndrew E. Jaffe
Andrew E. Jaffe
RTRan Tao
Ran Tao
ADAmy Deep-Soboslay
Amy Deep-Soboslay
CSChang Shu
Chang Shu
BMBrion S. Maher
Brion S. Maher
Although preclinical models reveal the neurobiological pathways altered through opioid abuse, comprehensive assessments of gene expression in human brain samples are needed. Moreover, less is known about gene expression in response to fatal overdose. The primary goal of the present study was to compare gene expression in the dorsolateral prefrontal cortex (DLPFC) between brain samples of individuals who died of acute opioid intoxication and group-matched controls. Postmortem tissue samples of the DLPFC from 153 deceased individuals (Mage = 35.4; 62% male; 77% European ancestry). Study groups included 72 brain samples from individuals who died of acute opioid intoxication, 53 psychiatric controls, and 28 normal controls. Whole transcriptome RNA-sequencing was used to generate exon counts, and differential expression was tested using limma-voom. Analyses were adjusted for relevant sociodemographic characteristics, technical covariates, and cryptic relatedness using quality surrogate variables. Weighted correlation network analysis and gene set enrichment analyses also were conducted. Two genes were differentially expressed in opioid samples compared to control samples. The top gene, NPAS4, was downregulated in opioid samples (log2FC = -2.47, adj. p = .049) and has been implicated in opioid, cocaine, and methamphetamine use. Weighted correlation network analysis revealed 15 gene modules associated with opioid overdose, though no intramodular hub genes were related to opioid overdose, nor were pathways related to opioid overdose enriched for differential expression. Results provide preliminary evidence that NPAS4 is implicated in opioid overdose, and more research is needed to understand its role in opioid abuse and associated outcomes.